CompanyTTRXNasdaqWestlake Village, CA

Turn Therapeutics

Turn Therapeutics develops targeted, non-systemic therapies for disease sites.

SEC EDGAR ClinicalTrials.gov ir.turntherapeutics.com

8-KSep 10Latest SEC filing, period to Sep 10

Sep 10Latest story

September 2026

Turn Therapeutics names Redfield chief scientific officer, sets Stifel forum date

Sep 10PeopleTurn Therapeutics

August 2026

Turn Therapeutics discloses $1.65 million equity raise in Form D filing

Aug 26FinancingTurn Therapeutics

Turn Therapeutics discloses GEM's cashless warrant exercise for 579,664 shares

Aug 18FinancingTurn Therapeutics

Turn Therapeutics expands Phase 2 atopic dermatitis trial after interim data review

Aug 12Quarterly updateTurn Therapeutics